Abstract:Previous studies have revealed the relationship between toll-like receptor 4 ( TLR4 ) polymorphisms and cancer susceptibility. However, the relationship between TLR4 and prognosis and immune cell infiltration in pan-cancer patients is still unclear. Through the Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) databases, the distinct expression of the TLR4 gene in 24 tumors and normal tissues was analyzed. Univariate Cox proportional hazards regression analysis was used to identify the cancer types whose TLR4 gene expression was related to prognosis. The relationship between TLR4 and tumor cell immune invasion was studied. Spearman’s rank correlation coefficient was used to analyze the relationship among TLR4 and immune neoantigens, tumor mutation burden (TMB), microsatellite instability (MSI), DNA repair genes, and DNA methylation. Gene Set Enrichment Analysis (GSEA) was used to identify the tumor-related pathways that the TLR4 gene was highly expressed in; the expression of the TLR4 gene was verified with the Human Protein Atlas (HPA) database. Low expression of TLR4 was associated with an inferior prognosis in kidney renal clear cell carcinoma (KIRC), skin cutaneous melanoma (SKCM), and uterine corpus endometrial carcinoma (UCEC), while high expression was related to a poor prognosis in head and neck squamous cell carcinoma (HNSC), prostate adenocarcinoma (PRAD), stomach adenocarcinoma (STAD), and testicular germ cell tumor (TGCT). The expression of TLR4 was negatively correlated with the expression of B cells in STAD. The expression of TLR4 was positively correlated with the infiltration of B cells, CD4 and CD8 T cells, neutrophils, macrophages, and dendritic cells in STAD, KIRC, UCEC, TGCT, and SKCM. The expression of the TLR4 gene in KIRC, SKCM, STAD, TGCT, and UCEC was highly correlated with inducible T-cell costimulator ( ICOS ), cytotoxic T lymphocyte-associated molecule 4 ( CTLA4 ), and CD28 immune checkpoints. Spearman’s rank correlation coefficient showed that the expression of TLR4 gene was significantly correlated with TMB in STAD and UCEC and was prominently correlated with MSI in TGCT, STAD, and SKCM. The expression of the TLR4 gene was highly correlated with MLH1, MSH2, and MSH6 in KIRC, SKCM, and STAD. The expression of the TLR4 gene was remarkably correlated with the methyltransferases DNA methyltransferase 2 (DNMT2) and DNA methyltransferase 3-beta (DNMT3B) in SKCM and STAD. Enrichment analysis showed that TLR4 was highly expressed in the chemokine signaling pathway and the cell adhesion molecule and cytokine receptor interaction pathway. In summary, the expression of TLR4 is linked to the prognosis of KIRC, SKCM, STAD, TGCT, and UCEC patients and the level of immune infiltration of CD4, CD8 T cells, macrophages, neutrophils, and dendritic cells.

[High expression of TCF-4 positively correlated with lung cancer progression.].

[The relationship between expressions of β-catenin and TCF-4 in non-small cell lung cancer].

Association of Htcf—4 Gene Expression and Mutation with Clinicopathological Characteristics of Hepatocellular Carcinoma

Expression of Telomeric Repeat Binding Factor 1 in Non-Small Cell Lung Cancer.

TC-1 (c8orf4) Enhances Aggressive Biologic Behavior in Lung Cancer Through the Wnt/β-catenin Pathway.

Expression of Tcf-4 Mrna in Colorectal Cancer Tissues

Differential Expression of the TLR4 Gene in Pan-Cancer and Its Related Mechanism

Characterization of TCF-1 and its relationship between CD8+ TIL densities and immune checkpoints and their joint influences on prognoses of lung adenocarcinoma patients

Expression and clinical significance of Transcription factor 4 (TCF4) in epithelial ovarian cancer.

Overexpression of Transcription Factor Activating Enhancer Binding Protein 4 (TFAP4) Predicts Poor Prognosis for Colorectal Cancer Patients.

TFAP2A-activated ITGB4 Promotes Lung Adenocarcinoma Progression and Inhibits CD4+/CD8++ /Cd8+t-Cell Infiltrations by Targeting NF-κB Κ B Signaling Pathway

Expression of OCT-4 in Lung Cancer and Its Clinical Significance

Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma

Study on the expression and mutation of hTcf-4 gene in liver cancer cell lines

Mining TCGA and GEO Databases for the Prediction of Poor Prognosis in Lung Adenocarcinoma Based on Up-Regulated Expression of TNS4

Overexpression of Axin Downregulates TCF-4 and Inhibits the Development of Lung Cancer.

Expression of Zinc Finger and BTB Domain-Containing 4 in Colorectal Cancer and Its Clinical Significance.

Genome-wide ChIP-seq analysis of TCF4 binding regions in colorectal cancer cells.

TFAP2A-activated ITGB4 promotes lung adenocarcinoma progression and inhibits CD4+/CD8+ T-cell infiltrations by targeting NF-κB signaling pathway

TCF3 as a multidimensional biomarker: oncogenicity, genomic alterations, and immune landscape in pan-cancer analysis

Identification of CFHR4 Associated with Poor Prognosis of Hepatocellular Carcinoma